Waregem (Belgium) / Rotterdam (Netherlands)[1], 16 April 2014 – Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Arseus NV received notifications (above 3%) on 11 April 2014 from AXA S.A. and on 16 April 2014 of Carmignac Gestion concerning the acquisition of voting securities.
We are delighted to announce that on 11 April AXA S.A. reported a shareholding of 4.51% and on 16 April Carmignac Gestion reported a shareholding of 4.45% in Arseus NV. On 9 April the shareholding of JP Morgan Asset Management UK Ltd. has fallen below the disclosure threshold of 3%.
Based on the denominator of 31,358,358 (total number of voting rights) and the relevant notifications that Arseus received, the shareholder structure as of 16 April 2014 is as follows:
Number of shares % of effective voting rights BNP Paribas Investment Partners SA 1,609,182 5.13% AXA S.A. 1,413,820 4.51% Carmignac Gestion 1,396,407 4.45% Fidelity Management and Research (FMR LLC) 1,223,000 3.90% Arseus NV (treasury shares) 881,378 2.81% Public 24,834,571 79.20% Total 31,358,358 100.00%The original notification forms are available at www.arseus.com.
In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.
For more information:
Marieke Palstra
Director Investor Relations
+31 88 33 11 213 (Office)
marieke.palstra@arseus.com
[1] This press release was sent out by Arseus NV and Arseus BV.
Please open the link below for the press release: